• Top in endocrinology: Obesity treatment, COVID-19 mortality in metformin users

    One year ago - By Healio

    A once-monthly monoclonal antibody reduced body fat and increased muscle in patients with type 2 diabetes and overweight or obesity, according to a recent study. It was the top story in endocrinology last week.
    Another top story was about an association between metformin use and reduced odds of COVID-19 mortality.
    Read these and more in endocrinology below:
    Once-monthly monoclonal antibody reduces body fat, increases muscle in obesity, diabetes
    Adults with type 2 diabetes and overweight or obesity assigned a once-monthly monoclonal antibody infusion experienced a marked decrease in fat...
    Read more ...

     

  • Covid-19 Has Affected Treatment of Osteoporosis

    Covid-19 Has Affected Treatment of Osteoporosis

    One year ago - By Medindia Health

    Covid-19 pandemic has brought alterations in global osteoporosis care, assessment and treatment, including delays in DXA scanning, interrupted supply of medicines and delivery of medication, and increase in telemedicine consultations.
    Read more ...